Science Aug 10 Groups make own drugs to fight high drug prices, shortages Impatient with years of inaction in Washington on prescription drug prices, U.S. hospital groups, startups and nonprofits have started making their own medicines.
Health Jul 28 FDA allows automatic ‘generic’ swap for brand-name insulin Wednesday's move by the Food and Drug Administration will allow pharmacists to automatically substitute the cheaper version, just as they do with generic pills for other kinds of drugs.
Economy Jul 15 Johnson & Johnson recalling sunscreens due to benzene traces J&J said it's unlikely users would be harmed. The recall includes all can sizes and all levels of SPF, or sun protection factor. Consumers can contact the company for a refund.
Health Jun 14 Novavax data suggests its COVID-19 vaccine is highly effective While demand for COVID-19 shots in the U.S. has dropped off dramatically, the need for more vaccines around the world remains critical.
Health Jun 11 Johnson & Johnson vaccine doses to be released, but many will be tossed The Food and Drug Administration announced that it had determined that two batches from the plant could be released. But it said several other batches are not suitable for use and additional batches are still under review.
Health Apr 01 Company at heart of Johnson & Johnson vaccine woes has series of citations The company at the center of quality problems that led Johnson & Johnson to discard a batch of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems.
Health Mar 05 WATCH: White House COVID-19 response team holds briefing The White House says two new mass vaccination sites will soon be open, in Atlanta and Cleveland, each with the ability to provide 6,000 daily coronavirus shots.
Health Mar 02 U.S. will be able to vaccinate all adults by end of May, Biden says Drugmaker Merck & Co. will help produce rival Johnson & Johnson's newly approved coronavirus vaccine in an effort to expand supply more quickly.
Health Jan 29 Johnson & Johnson’ single-shot vaccine is 66 percent effective against COVID-19 With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.
Health Oct 23 AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.